CAS 2561414-57-9

Fórmula: C24H31ClN6O2

InChI: InChI=1S/C24H30N6O2.ClH/c1-2-28-9-11-29(12-10-28)24(31)27-23-15-18(3-8-26-23)21-17-30(19-5-13-32-14-6-19)22-16-25-7-4-20(21)22;/h3-4,7-8,15-17,19H,2,5-6,9-14H2,1H3,(H,26,27,31);1H

Chave InChI: PKSHRWPMQDLRRB-UHFFFAOYSA-N

SMILES: CCN1CCN(CC1)C(=O)NC2=NC=CC(=C2)C3=CN(C4=C3C=CN=C4)C5CCOCC5.Cl

4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide hydrochloride

CAS: 2561414-57-9

4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide hydrochloride

Fórmula: C₂₄H₃₁ClN₆O₂

Pureza: 98%

Peso molecular: 470.99

Ref: 54-OR1175326

4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide hydrochloride

CAS: 2561414-57-9

Fórmula: C₂₄H₃₁ClN₆O₂

Pureza: 98%

Peso molecular: 470.9949

Ref: IN-DA0248XN

GNF2133 hydrochloride

CAS: 2561414-57-9

GNF2133 hydrochloride: selective oral DYRK1A inhibitor (IC50: 0.0062 μM), boosts β-cell growth and insulin, potential for type 1 diabetes research.

Fórmula: C₂₄H₃₁ClN₆O₂

Cor e Forma: Solid

Peso molecular: 471.0

Ref: TM-T63040